Where volume actually affects cost on FountainRx
Volume shows up in payor formulary negotiations and manufacturer assistance programs, not in a clinic-facing tier table. FountainRx states it connects patients to financial assistance and works with insurers on coverage for high-cost therapies. A patient on a plan with strong GLP-1 or specialty benefits may see lower out-of-pocket than a patient on a high-deductible plan — regardless of how many patients your clinic refers in a month.
Providers evaluating FountainRx for volume should ask coordinators how assistance programs apply to their patient mix, not how referral count changes a wholesale semaglutide rate. That question belongs to a different category: clinic commerce platforms built for cash-pay batch ordering.